Standard‐dose VKA plus single antiplatelet agent vs vitamin K antagonist (VKA)
The review found no eligible studies for this question.
- Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people… 2020 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found